US$ 27.33
abbvie glp-1 receptor agonist weight management diabetes treatments How Agonists Evolved from to Loss abbvie glp-1 receptor agonists weight
Description
(2024) 48:S32134

Diabetes: From Research to Clinical Practice

The combination of the glucagon like peptide-1 receptor agonist semaglutide and the progestin levonorgestrel is highly effective in preclinical studies of endometrial cancer

14 Pairing sitagliptin with metformin is a good combination, because metformin is commonly used as initial therapy due to the absence of weight gain and hypoglycemia

2 Although the pancreatic effects of GLP-1 (glucose-dependent insulin secretion and glucagon suppression) are well-established, its extrapancreatic actions are increasingly being recognised as critical to the therapeutic effects of GLP-1RAs
